Last year, an estimated 314,000 people worldwide developed ovarian cancer, a condition associated with a 50% mortality rate. Alternatively, nearly 90% of people with breast cancer will survive for at least five years after diagnosis.
Between 2007 and 2014, the US National Cancer Institute provided nearly 19 times more funding for breast cancer research than it did for the study of ovarian cancer (Nature 2021). However, with the burden of ovarian cancer only expected to rise, it is fortunate that advances in understanding ovarian cancer have begun to improve the standard of care (e.g., the advent of PARP inhibitors).
With the burden of ovarian cancer only expected to rise, it is fortunate that advances in understanding ovarian cancer have begun to improve the standard of care.
Similarly, the realization that many cases of ovarian cancer arise in the fallopian tubes is inspiring clinical trials that study the impact of preventive surgeries. Also, there is increased momentum to address disparities in ovarian cancer care between Black and White women. However, screening programs have not resulted in decreased mortality.
Currently, the most effective predictive approach involves a person’s genetic make-up although genetic testing does yet appear to improve patient outcomes.
About Women’s Cancer Research Foundation The Women’s Cancer Research Foundation (WCRF) is one of Southern California’s and the nation’s most active research organizations for female cancers. We are dedicated to serving the interests of patients, families, and friends affected by women’s cancers. WCRF partners with physician-scientists nationally to make differences in women’s lives by offering hope, strength, and progress.
Laguna Beach, CA 92651
PH: (949) 642-5165
Follow Us On Social Media: